CELU Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
5.4M
+41.2%
3.8M
-6.3%
4.1M
-22.3%
5.3M
-7.9%
5.7M
Cost of Revenue
2.3M
+61.6%
1.5M
-80.3%
7.4M
+88.9%
3.9M
-25.5%
5.2M
Gross Profit
3.1M
+28.9%
2.4M
+173.2%
-3270000
-337.0%
1.4M
+179.4%
494.0K
Operating Expenses
7.3M
-41.6%
12.5M
-33.3%
18.8M
+31.6%
14.3M
-12.7%
16.4M
R&D
2.0M
-32.3%
3.0M
-10.5%
3.3M
-27.2%
4.6M
+37.2%
3.4M
SG&A
4.9M
-46.1%
9.2M
-39.2%
15.1M
+61.9%
9.3M
-26.3%
12.6M
Operating Income
-4237000
+58.2%
-10133000
+54.1%
-22058000
-71.0%
-12900000
+18.7%
-15864000
EBITDA
-2698000
+68.4%
-8536000
+57.8%
-20204000
-81.6%
-11127000
+20.7%
-14030000
Net Income
706.0K
+4.6%
675.0K
+102.8%
-24362000
-5.6%
-23076000
+5.9%
-24524000
EPS (Basic)
$0.02
+0.0%
$0.02
+102.3%
$-0.86
+2.3%
$-0.88
+13.7%
$-1.02
EPS (Diluted)
$0.02
+0.0%
$0.02
+102.3%
$-0.86
+2.3%
$-0.88
+13.7%
$-1.02
Shares (Diluted)
29.3M
-3.2%
30.3M
+6.3%
28.5M
+8.2%
26.3M
+9.7%
24.0M
Celularity (CELU) โ€” Financials